Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 19,811 | 7,992 | N/A | N/A |
| Marketable Securities | N/A | 8,348 | N/A | N/A |
| TOTAL | $20,703 | $17,315 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,026 | 936 | N/A | N/A |
| Other Non-Current Assets | 310 | 0 | 0 | 0 |
| TOTAL | $1,336 | $936 | $N/A | $N/A |
| Total Assets | $22,039 | $18,251 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 427 | 508 | 0 | 0 |
| Accrued Expenses | 804 | 458 | N/A | N/A |
| TOTAL | $1,231 | $966 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 30 | 0 | 0 | 0 |
| TOTAL | $30 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,261 | $966 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -26,324 | -11,882 | N/A | N/A |
| Other shareholders' equity | 47,102 | 29,167 | 0 | 0 |
| TOTAL | $20,778 | $17,285 | $N/A | $N/A |
| Total Liabilities And Equity | $22,039 | $18,251 | $0 | $0 |